Immune suppression via IL-4/IL-10-secreting T cells: A nontoxic property of anti-HIV agent Trichosanthin

Clinical Immunology

Volumn 122, Issue 3, 2007, Pages 312-322

  Zhou, Hong ^a   Jiao, Zhijun ^a   Pan, Jijun ^a   Hong, Jian ^a,c   Tao, Jiaxian ^a   Li, Ningli ^a   Zhou, Yun ^a,b   Zhang, Jingwu ^a,c   Chou, Kuang Yen ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b E institutes of Shanghai   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

CD8 T cell; HLA DQ; Immune suppression; Trichosanthin; Type 2 cytokines

Indexed keywords

HLA DQ ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; TRICHOSANTHIN;

APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL DAMAGE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ACTIVITY; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTI-HIV AGENTS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGEN-PRESENTING CELLS; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; TRICHOSANTHIN;

EID: 33846781510     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.11.001     Document Type: Article

References (55)

1. Wang Y., Qian R.Q., Gu Z.W., Jin S.W., Zhang L.Q., Xia Z.X., Tian G.Y., and Ni C.Z. Scientific evaluation of Tian Hua Fen (THF) - history, chemistry and application. Pure Appl. Chem. 58 (1986) 789-798
2. Collins E.J., Robertus J.D., Lopresti M., Stone K.L., Williams K.R., Wu P., Hwang K., and Piatak M. Primary amino acid sequence of alpha-trichosanthin and molecular models for abrin A-chain and alpha-trichosanthin. J. Biol. Chem. 265 (1990) 8665-8669
3. Chow T.P., Feldman R.A., Lovett M., and Piatak M. Isolation and DNA sequence of a gene encoding alpha-Trichosanthin, a type I ribosome-inactivating protein. J. Biol. Chem. 265 (1990) 8670-8674
4. Shaw P.C., Yung M.H., Zhu R.H., Ho W.K., Ng T.B., and Yeung H.W. Cloning of Trichosanthin cDNA and its expression in Escherichia coli. Gene 97 (1991) 267-272
5. Zhang X.J., and Wang J.H. Homology of Trichosanthin and ricin A chain. Nature 321 (1986) 477-478
6. Jin Y.C. Crystal trichosanthin protein intramuscular or intracervical injection for the termination of pregnancy at 10 to 14 weeks gestation: clinical analysis of 200 cases. Reprod. Contracept. 10 (1990) 34-37
7. Gu Z.F., Wu X.D., Li Y.J., Zhang P.Z., Guo X.M., and Lu S.F. Application of trichosanthin in 179 difficult cases of artificial abortion. Reprod. Contracept. 5 (1985) 10-14
8. Chan W.Y., Huang H., and Tam S.C. Receptor-mediated endocytosis of trichosanthin in choriocarcinoma cells. Toxicology 186 (2003) 191-203
9. Wang Q.C., Ying W.B., Xie H., Zhang Z.C., Yang Z.H., and Ling L.Q. Trichosanthin-monoclonal antibody conjugate specifically cytotoxic to human hepatoma cells in vitro. Cancer. Res. 51 (1991) 3353-3355
10. Brigotti M., Carnicelli D., Alvergna P., Pallanca A., Sperti S., and Montanaro L. Differential up-regulation by tRNAs of ribosome-inactivating proteins. FEBS Lett. 373 (1995) 115-118
11. Zhang J.S., and Liu W.Y. The mechanism of action of trichosanthin on eukaryotic ribosomes-RNA N-glycosidase activity of the cytotoxin. Nucleic Acids Res. 20 (1992) 1271-1275
12. Li M.X., Yeung H.W., Pan L.P., and Chan S.I. Trichosanthin, a potent HIV-1 inhibitor, can cleave supercoiled DNA in vitro. Nucleic Acids Res. 19 (1991) 6309-6312
13. Chan S.H., Hung F.S., Chan D.S., and Shaw P.C. Trichosanthin interacts with acidic ribosomal proteins P0 and P1 and mitotic checkpoint protein MAD2B. Eur. J. Biochem. 268 (2001) 2107-2112
14. Ding Y., Too H., Wang Z., Liu Y., Bartlam M., Dong Y., Wong K., Shaw P., and Rao Z. The structural basis of Trp192 and the C-terminal region in trichosanthin for activity and conformational stability. Protein Eng. 16 (2003) 351-356
15. He X.H., Shaw P.C., Xu L.H., and Tam S.C. Site-directed polyethylene glycol modification of trichosanthin: effects on its biological activities, pharmacokinetics, and antigenicity. Life Sci. 64 (1999) 1163-1175
16. Ke Y.B., Chen J.K., Nie H.L., He X.H., Ke X.Y., and Wang Y.H. Structure-function relationship of Trichosanthin. Life Sci. 60 (1997) 465-472
17. Shaw P.C., Mulot S., Ma S.K., Xu Q.F., Yao H.B., Wu S., Lu X.H., and Dong Y.C. Structure/function relationship study of Tyr14 and Arg22 in trichosanthin, a ribosome-inactivating protein. Eur. J. Biochem. 245 (1997) 423-427
18. Li N.L., Zhen Z.X., Shen B.H., Huang L.D., and Chou K.Y. Apoptosis of human blood leucocytes induced by Trichosanthin. Chinese J. Immunol. 11 (1995) 539-542
19. Kong M., Ke Y.B., Zhou M.Y., Ke X.Y., Lu B., and Nie H.L. Study on Trichosanthin induced apoptosis of leukemia K562 cells. Acta Biol. Exp. Sin. 31 (1998) 233-243
20. Hong J., Fu S.L., Shen Z.Y., Lu P.H., and Chou K.Y. Trichosanthin inhibits T cell activation by interfering with the recruitment of ZAP-70 to CD3 zeta chain. Cell Res. 8 (1998) 33-39
21. Nie H., Cai X., He X., Xu L., Ke X., Ke Y., and Tam S.C. Position 120-123, a potential active site of Trichosanthin. Life Sci. 62 (1998) 491-500
22. Ng T.B., Shaw P.C., and Chan W.Y. Importance of the Glu 160 and Glu 189 residues to the various biological activities of the ribosome inactivating protein Trichosanthin. Life Sci. 58 (1996) 2439-2446
23. McGrath M.S., Hwang K.M., Caldwell S.E., Gaston L., Luk K.C., Wu P., Ng V.L., Crowe S., Daniels J., and Marsh J. LQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2844-2848
24. Wang J.H., Nie H.L., Tam S.C., Huang H., and Zheng Y.T. Anti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity. FEBS. Lett. 531 (2002) 295-298
25. Byers V.S., Levin A.S., Waites L.A., Starrett B.A., Mayer R.A., Clegg J.A., Price M.R., Robins R.A., Delaney M., and Baldwin R.W. A phase I/II study of trichosanthin treatment of HIV disease. AIDS 4 (1990) 1189-1196
26. Mayer R.A., Sergios P.A., Coonan K., and O'Brien L. Trichosanthin treatment of HIV-induced immune dysregulation. Eur. J. Clin. Invest. 22 (1992) 113-122
27. Kahn J.O., Kaplan L.D., Gambertoglio J.G., Bredesen D., Arri C.J., Turin L., Kibort T., Williams R.L., Lifson J.D., and Volberding P.A. The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study. AIDS 4 (1990) 1197-1204
28. Pulliam L., Herndier B.G., and McGrath M.S. Purified Trichosanthin (GLQ223) exacerbation of indirect HIV-associated neurotoxicity in vitro. AIDS 5 (1991) 1237-1242
29. Lee-Huang S., Huang P.L., Kung H.F., Li B.Q., Huang P.L., Huang P., Huang H.I., and Chen H.C. TAP 29: an anti-human immunodeficiency virus protein from Trichosanthes kirilowii that is nontoxic to intact cells. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 6570-6574
30. Wang Y.X., Neamati N., Jacob J., Palmer I., Stahl S.J., Kaufman J.D., Huang P.L., Huang P.L., Winslow H.E., Pommier Y., Wingfield P.T., Lee-Huang S., Bax A., and Torchia D.A. Solution structure of anti-HIV-1 and anti-tumor protein MAP30: structural insights into its multiple functions. Cell 99 (1999) 433-442
31. Zhao J., Ben L.H., Wu Y.L., Hu W., Ling K., Xin S.M., Nie H.L., Ma L., and Pei G. Anti-HIV agent trichosanthin enhances the capabilities of chemokines to stimulate chemotaxis and G protein activation, and this is mediated through interaction of trichosanthin and chemokine receptors. J. Exp. Med. 190 (1999) 101-111
32. Chan W.L., Shaw P.C., Tam S.C., Jacobsen C., Gliemann J., and Nielsen M.S. Trichosanthin interacts with and enters cells via LDL receptor family members. Biochem. Biophys. Res. Commun. 270 (2000) 453-457
33. Fan Z.S., and Ma B.L. IL-10 and trichosanthin inhibited surface molecule expression of antigen processing cells and T-cell proliferation. Acta Pharmacol. Sin. 20 (1999) 353-357
34. Xu W., Hou W., Yao G., Ji Y., Yeh M., and Sun B. Inhibition of Th1- and enhancement of Th2-initiating cytokines and chemokines in Trichosanthin-treated macrophages. Biochem. Biophys. Res. Commun. 284 (2001) 168-172
35. Chou K.Y., Zhang D.Q., and Xue B.H. Human immune suppression is inducible by Trichosanthin via CD8 cell-mediated pathway. Cell Res. 4 (1994) 17-29
36. Chou K.Y., Chan M., and Bias W.B. Differential expression of the down-regulatory function of CD8 cells in Trichosanthin-induced immunosuppression and its genetic control in humans. Eur. J. Immunogenet. 23 (1996) 29-40
37. Chou K.Y., Fu S.L., Li N.L., Huang L.D., Wang F.Q., Lu P.H., and Fan L.A. Cis-trans complementation of DQA1-DQB1 genes are modulated by DQ alleles: an immunogenetics analysis of DQ association with the down-regulatory function of CD8 cells in trichosanthin-induced immunosuppression. Eur. J. Immunogenet. 26 (1999) 5-13
38. Hisano S., Adachi T., and Daikoku S. Immunolabeling of adenohypophysial cells with protein A-colloidal gold-antibody complex for electron microscopy: use of the freeze-substitution technique in tissue preparation. J. Histochem. Cytochem. 32 (1984) 705-711
39. Sambrook J., and Russell D.W. Molecular Cloning: A Laboratory Manual. 3rd ed (2003), Cold Spring Harbor Laboratory Press, New York
40. Wang F.Q., Semana G., Fauchet R., and Genetet B. HLA-DR and DQ genotyping by PCR-SSO in Shanghai Chinese. Tissue Antigens 38 (1993) 223-226
41. Salgame P., Convit J., and Bloom B.R. Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 2598-2602
42. de Bakker P.I.W., McVean G., Sabeti P., et al. A high resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 38 (2006) 1166-1172
43. Baas A., Gao X., and Chelvanayagam G. Peptide binding motifs and specificities for HLA-DQ molecules. Immunogenetics 50 (1999) 8-15
44. Pollack M.S., Gold J., Metroka C.E., Safai B., and Dupont B. HLA-A,B,C and DR antigen frequencies in acquired immunodeficiency syndrome (AIDS) patients with opportunistic infections. Hum. Immunol. 11 (1984) 99-103
45. Kaslow R.A., Duquesnoy R., VanRaden M., Kingsley L., Marrari M., Friedman H., Su S., Saah A.J., Detels R., and Phair J. A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the multicenter AIDS cohort study. Lancet 335 (1990) 927-930
46. Stephens H.A.F. HIV-1 diversity versus HLA class I polymorphism. Trend Immunol. 26 (2005) 41-47
47. Levy J.A., Mackewicz C.E., and Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol. Today 17 (1996) 217-224
48. Walker C.M., Erickson A.L., Hsueh F.C., and Levy J.A. Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism. J. Virol. 65 (1991) 5921-5927
49. Chess L., and Jiang H. Resurrecting CD8+ suppressor T cells. Nat. Immunol. 5 (2004) 469-471
50. Sarantopoulos S., and Lu Cantor H L. Qa-1 restriction of CD8+ suppressor T cells. J. Clin. Invest. 114 (2004) 1218-1221
51. Suciu-Foca N., Manavalan J.S., and Cortesini R. Generation and function of antigen-specific suppressor and regulatory T cells. Transplant Immunol. 11 (2003) 235-244
52. Scotto L., Naiyer A.J., Galluzzo S., Rossi P., Manavalan J.S., Kim-Schulze S., Fang J., Favera R.D., Cortesini R., and Suciu-Foca N. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells. Hum. Immunol. 65 (2004) 1297-1306
53. Vukmanovic-Stejic M., Thomas M.J., Noble A., and Kemeny D.M. Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells. Immunology 102 (2001) 115-122
54. Bandres E., Merino J., Vazquez B., Inoges S., Moreno C., Subira M.L., and Sanchez-Ibarrola A. The increase of IFN-gamma production through aging correlates with the expanded CD8 (+high) CD28(-) CD57(+) subpopulation. Clin. Immunol. 96 (2000) 230-235
55. Najafian N., Chitnis T., Salama A.D., et al. Regulatory function of CD8+CD28- T cells in an autoimmune disease model. J. Clin. Invest. 112 (2003) 1037-1048